PRESTIGE BIOLOGICS CO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 334970 for the last quarter is 638.83 M KRW, and it's 14.91% lower compared to the previous quarter. The net income of Q3 24 is -15.77 B KRW.